Sam Brusco, Associate Editor10.06.23
LivaNova has named J. Christopher (Chris) Barry to its board, effective today, to serve on the Audit and Compliance Committee. Andrea Saia, who has been a board director since 2016, also announced voluntary retirement from the company’s board on December 31, 2023.
Barry has over 20 years of experience serving the medical device industry and was most recently CEO and director of spine surgery company NuVasive from November 2018 until last month’s merger with Globus Medical.
Before that, he was senior VP and president of Surgical Innovations at Medtronic and spent 15 years at Covidien before its acquisition in various sales and leadership positions. The most recent at Covidien—from October 2013 to January 2015—was president of Advanced Surgical Technologies.
“I am honored to join the LivaNova Board of Directors and look forward to supporting the efforts to bring life-changing improvements to patients around the world, while maximizing value to the shareholders,” Barry told the press.
Earlier this year, LivaNova revealed that CEO Damien McDonald resigned from his role with no reasons given. He officially departed the company on May 31. Board chair William A. Kozy was quickly instated as interim CEO and remains in the position today as the company continues the search for a permanent CEO.
“The LivaNova Board of Directors is pleased to welcome Chris Barry,” Kozy said. “Chris has spent his career in the medical technology industry, and we look forward to adding his commercial expertise and ability to drive long-term growth to the Board. Additionally, on behalf of the entire Board, I’d like to thank Andrea for her many contributions, notably her ability to offer frequent insights on talent, share marketing expertise and her overall positivity brought clear value to our Board.”
Barry has over 20 years of experience serving the medical device industry and was most recently CEO and director of spine surgery company NuVasive from November 2018 until last month’s merger with Globus Medical.
Before that, he was senior VP and president of Surgical Innovations at Medtronic and spent 15 years at Covidien before its acquisition in various sales and leadership positions. The most recent at Covidien—from October 2013 to January 2015—was president of Advanced Surgical Technologies.
“I am honored to join the LivaNova Board of Directors and look forward to supporting the efforts to bring life-changing improvements to patients around the world, while maximizing value to the shareholders,” Barry told the press.
Earlier this year, LivaNova revealed that CEO Damien McDonald resigned from his role with no reasons given. He officially departed the company on May 31. Board chair William A. Kozy was quickly instated as interim CEO and remains in the position today as the company continues the search for a permanent CEO.
“The LivaNova Board of Directors is pleased to welcome Chris Barry,” Kozy said. “Chris has spent his career in the medical technology industry, and we look forward to adding his commercial expertise and ability to drive long-term growth to the Board. Additionally, on behalf of the entire Board, I’d like to thank Andrea for her many contributions, notably her ability to offer frequent insights on talent, share marketing expertise and her overall positivity brought clear value to our Board.”